Abstract: The present invention provides a genus of bis-benzimidazole compounds, methods and pharmaceutical compositions that are useful as modulators of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.

Abstract: A method for screening compounds for biological activity is disclosed. A test library of compounds is selected. Then, a first analytical model is formed using a first recursive partitioning process. The first recursive partitioning process is performed on at least some of the compounds in the test library of compounds and uses a first descriptor set. Subsequent analytical models are formed using subsequent recursive partitioning processes using the digital computer and use multiple descriptor sets. A consensus compound set is determined using the first analytical model and one or more of the subsequent analytical models.

Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.